Akari Therapeutics (AKTX) Stock Price, Quote, News & History | Benzinga

Akari Therapeutics PLC (AKTX) Stock Price, Quote, News & History

AKTXNASDAQ

Trade with Public

Trade with Public

$8.08

0.587.73%

At close: Aug 6, 5:00 PM EST

$7.50

-0.58-7.18%

After Hours: 9:16 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.88

Close

$8.08

Volume / Avg.

11.04K / 771.53K

Day Range

$7.31 - $8.09

52 Wk Range

3.02 - 49.60

Market Cap

$13.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

1.79%

Days to Cover

1

Recent Akari Therapeutics PLC News

Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pre-market trading while other stocks also saw gains/losses.

Avi Kapoor

VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures up, VNET Group shares down 3.8% after reporting Q1 loss of $(1.20) per share on $390.133 million sales. Other stocks also fall.

Avi Kapoor

Why Akari Therapeutics Stock Is Falling On Tuesday?

Discover why Akari Therapeutics PLC (NASDAQ: AKTX) stock is falling on Tuesday after last week's massive 255% rally on positive preclinical cancer data.

Kaustubh Bagalkote

Why JOYY Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%

Avi Kapoor

Crude Oil Edges Higher; US Consumer Sentiment Falls In May

US stocks rose, Dow gained over 400 points. S&P 500 and NASDAQ also up. Health care shares jumped, while communication services fell. University of Michigan's consumer sentiment index hit record low. Oil up, gold and silver down. European and Asian markets closed higher.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-10.91M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

11.09M

Free Cash Flow (TTM)

-10.91M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

185.00K

Analyst Trends and Forecast

1

Apr

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$10.72M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.89

Earnings Yield % (TTM)

0.00%

Earnings Yield % (FWD)

-175.58%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$8.22

Company Debt

Total Debt

$732.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$2.77M

Debt to Equity

0.05

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$673.00K

Key Statistics

Open

$7.88

Close

$8.08

Volume / Avg.

11.04K / 771.53K

Day Range

$7.31 - $8.09

52 Wk Range

3.02 - 49.60

Market Cap

$13.13M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

39

Short Interest

1.79%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the sp...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Akari Therapeutics (AKTX) stock?

A

You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Akari Therapeutics (AKTX) competitors?

A

There are no as such competitors for Akari Therapeutics.

Q

What is the forecast, or price target, for Akari Therapeutics (AKTX) stock?

A

Akari Therapeutics has a consensus price target of $19.33.

Q

What is the current price for Akari Therapeutics (AKTX)?

A

The stock price for Akari Therapeutics (NASDAQ: AKTX) is $7.5 last updated August 6, 2026 at 9:16 AM EDT.

Q

Does Akari Therapeutics (AKTX) pay a dividend?

A

There are no upcoming dividends for Akari Therapeutics.

Q

When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?

A

Akari Therapeutics does not have any upcoming earnings scheduled.

Q

Is Akari Therapeutics (AKTX) going to split?

A

There is no upcoming split for Akari Therapeutics.

Q

What sector and industry does Akari Therapeutics (AKTX) operate in?

A

Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.